BMO Capital analyst Kostas Biliouris downgrades Graphite Bio (NASDAQ:GRPH) from Outperform to Market Perform and lowers the price target from $14 to $7.
BMO Capital analyst Etzer Darout downgrades Fate Therapeutics (NASDAQ:FATE) from Outperform to Market Perform and lowers the price target from $20 to $7.
Piper Sandler analyst Abbie Zvejnieks downgraded Wolverine World Wide, Inc. (NYSE: WWW) to Neutral from Overweight and reduced the price target from $23…
Shares of Victoria's Secret & Co (NYSE: VSCO) tumbled in early trading on Thursday.
The company’s growth prospects are limited by a challenging macro environment, according to UBS.